Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...

Advances Pacira’s “5x30” path to becoming an innovative biopharmaceutical organization -- -- Adds novel, high-capacity, local ...

The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...

One way to address the opioid crisis is to clear away red tape and make other pain treatments more easily available, Rep. Melanie Stinnett writes.

Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management ...

Leaders with Project Opioid, a non-profit established after the opioid epidemic was declared a public health emergency in 2017, said the trend of declining overdose deaths is encouraging, but there is ...

The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.

Behind pharmacy counters across Arkansas, pharmacists serve as the link between health-care providers and patients managing pain. While they work diligently to ensure safe medication use and counsel ...